Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real-world data approach Posted on October 10th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Incidence and outcomes of cardiovascular implantable electronic device infections in patients with end-stage kidney disease.Next: Single-chamber atrial pacing + Micra AV implantation: A case report.
Incidence and outcomes of cardiovascular implantable electronic device infections in patients with end-stage kidney disease. Posted on October 10th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Trends in adoption of extravascular cardiac implantable electronic devices: the Dutch cohort.Next: Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real-world data approach
Trends in adoption of extravascular cardiac implantable electronic devices: the Dutch cohort. Posted on October 10th, 2024 by LEADconnection Bookmark Please login to bookmarkClose Username or Email Address Password Remember Me Post navigation Previous: Conduction system pacing associated with reduced heart failure hospitalizations and all-cause mortality compared with traditional right ventricular pacing in the Medicare populationNext: Incidence and outcomes of cardiovascular implantable electronic device infections in patients with end-stage kidney disease.